Multicenter, Double-Blind, Randomized, Parallel-Group Study to Assess the Efficacy and Safety of MYL-1402O Compared With Avastin®, in the First-line Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer
Phase of Trial: Phase III
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Bevacizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Mylan
- 31 Jan 2018 This trial has been Suspended in Spain according to European Clinical Trials Database record.
- 22 May 2017 Status changed from Not yet recruiting to Recruiting.
- 12 May 2015 New trial record